Fujii, Tomoko; Salanti, Georgia; Belletti, Alessandro; Bellomo, Rinaldo; Carr, Anitra; Furukawa, Toshi A; Luethi, Nora; Luo, Yan; Putzu, Alessandro; Sartini, Chiara; Tsujimoto, Yasushi; Udy, Andrew A; Yanase, Fumitaka; Young, Paul J (2022). Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis. Intensive care medicine, 48(1), pp. 16-24. Springer-Verlag 10.1007/s00134-021-06558-0
|
Text
Fujii_IntensiveCareMed_2021_epub.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (842kB) | Preview |
We aimed to compare the effects of vitamin C, glucocorticoids, vitamin B1, combinations of these drugs, and placebo or usual care on longer-term mortality in adults with sepsis or septic shock. MEDLINE, Embase, CENTRAL, ClinicalTrials.gov and WHO-ICTRP were searched. The final search was carried out on September 3rd, 2021. Multiple reviewers independently selected randomized controlled trials (RCTs) comparing very-high-dose vitamin C (≥ 12 g/day), high-dose vitamin C (< 12, ≥ 6 g/day), vitamin C (< 6 g/day), glucocorticoid (< 400 mg/day of hydrocortisone), vitamin B1, combinations of these drugs, and placebo/usual care. We performed random-effects network meta-analysis and, where applicable, a random-effects component network meta-analysis. We used the Confidence in Network Meta-Analysis framework to assess the degree of treatment effect certainty. The primary outcome was longer-term mortality (90-days to 1-year). Secondary outcomes were severity of organ dysfunction over 72 h, time to cessation of vasopressor therapy, and length of stay in intensive care unit (ICU). Forty-three RCTs (10,257 patients) were eligible. There were no significant differences in longer-term mortality between treatments and placebo/usual care or between treatments (10 RCTs, 7,096 patients, moderate to very-low-certainty). We did not find any evidence that vitamin C or B1 affect organ dysfunction or ICU length of stay. Adding glucocorticoid to other treatments shortened duration of vasopressor therapy (incremental mean difference, - 29.8 h [95% CI - 44.1 to - 15.5]) and ICU stay (incremental mean difference, - 1.3 days [95% CI - 2.2 to - 0.3]). Metabolic resuscitation with vitamin C, glucocorticoids, vitamin B1, or combinations of these drugs was not significantly associated with a decrease in longer-term mortality.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > University Emergency Center 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
UniBE Contributor: |
Salanti, Georgia, Lüthi, Nora |
Subjects: |
600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services |
ISSN: |
0342-4642 |
Publisher: |
Springer-Verlag |
Language: |
English |
Submitter: |
Andrea Flükiger-Flückiger |
Date Deposited: |
16 Nov 2021 19:50 |
Last Modified: |
29 Dec 2022 12:16 |
Publisher DOI: |
10.1007/s00134-021-06558-0 |
PubMed ID: |
34750650 |
Uncontrolled Keywords: |
Hydrocortisone Network meta-analysis Sepsis Systematic review Thiamine Vitamin C |
BORIS DOI: |
10.48350/161182 |
URI: |
https://boris.unibe.ch/id/eprint/161182 |